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Abstract: In the UK, 81% of all antibiotics are prescribed in primary care. Previous research has
shown that a letter from the Chief Medical Officer (CMO) giving social norms feedback to General
Practitioners (GPs) whose practices are high prescribers of antibiotics can decrease antibiotic pre-
scribing. The aim of this study was to understand the best way for engaging with GPs to deliver
feedback on prescribing behaviour that could be replicated at scale; and explore GP information
requirements that would be needed to support prescribing behaviour change. Two workshops were
devised utilising a participatory approach. Discussion points were noted and agreed with each group
of participants. Minutes of the workshops and observation notes were taken. Data were analysed
thematically. Four key themes emerged through the data analysis: (1) Our day-to-day reality, (2)
GPs are competitive, (3) Face-to-face support, and (4) Empowerment and engagement. Our findings
suggest there is potential for using behavioural science in the form of social norms as part of a range
of engagement strategies in reducing antibiotic prescribing within primary care. This should include
tailored and localised data with peer-to-peer comparisons.
Keywords: antibiotics; social norms; prescribing behaviour; feedback; primary care
1. Introduction
The extensive use of antibiotics in both human medicine and animal agriculture,
combined with the slow development of new compounds to treat infections has led to a
rapid evolution of Antimicrobial Resistance (AMR) [1]. If no action is taken to preserve
the effectiveness of existing antibiotics, resistance evolution will lead to the increase of
the burden on health services and increase infection-related mortality worldwide [2]. In
the U.K, 81% of all antibiotics are prescribed in primary care [3]. However, modelling has
shown that up to 23.1% of antibiotic prescribing is inappropriate, either having no benefit
to the patient or having a marginal benefit that is outweighed by potential risks [4].
Behavioural sciences are increasingly being used to improve the effectiveness of inter-
ventions by focusing on understanding and changing behaviours [5,6]. Social norms are a
way of influencing people’s behaviour by utilising indirect suggestions or interventions
as ways to (positively) influence the behaviour and decision making of individuals or a
group of people (such as the general population) by highlighting the compliance of the
majority [7].
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Since 2014, an annual feedback letter from the Chief Medical Officer (CMO) has
been sent to general practices, giving feedback on their prescribing compared to other
practices [8,9]. The content of the letter was based on a comprehensive review and analysis
of the behaviours that support antibiotic stewardship, and which of the drivers of these
behaviours are amenable to change [8].
All letters contain social norms feedback. In the first year, this was a comparison to
other prescribers in local area teams: ‘The great majority (80%) of practices in [local NHS
area team] prescribe fewer antibiotics per head than yours’ (see Figure 1 for a picture of
the letter). However, local area teams were disbanded and in subsequent years GPs were
given feedback compared to the national data [10]: ‘The great majority (80%) of practices
in England prescribe fewer antibiotics per head than yours’. GPs were directed to their
prescribing data on Fingertips, https://fingertips.phe.org.uk/profile/amr-local-indicators
(accessed on 29 June 2020). The antimicrobial prescribing indicators are updated quarterly,
appearing roughly three months after the end of the quarter they cover. This is due to
the time lag in receiving the data from NHS Business Authority and the time it takes to
quality check, process and upload the data [11]. Furthermore, the NHS Business Authority
currently only collects prescribing data at the level of the GP practice, and not the individual
GP, so feedback has always been of practice-level prescribing.
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Figure 1. Example of the first GP feedback letter sent to GP Practices in 2014.
All letters contain simple steps to reduce prescribing, and a copy of the ‘TARGET
treat your infection’ leaflet was enclosed with the letter as an aid for patient conversations.
Letters were usually sent to land at the beginning of September, however, for pragmatic
reasons that has not always been possible, but they have always been sent during the UK
flu season (September–March) since that is the time of year with the highest antibiotic
prescribing. In 2018/9 and 2019/20, as a part of Randomized Controlled Trials to see if
the content of the letter could be improved, some practices received letters with charts,
showing their previous year’s prescribing compared to the average prescribing of their
peers, where the annual prescribing data were based on the most recent 12-months of
prescribing available at the time of producing the letter [3].
This study investigated the effectiveness of current feedback letters and explored what
types of GP level prescribing data could be used in future feedback interventions. The
aim of this research was twofold: (1) to understand the best way for engaging with GPs
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in discussing prescribing behaviour that could be replicated at scale; and (2) to explore
the types of GP prescribing data that would be used to support changes to prescribing
behaviour change.
2. Methods
This study was based on qualitative data gathered through two workshops held
with GPs, other prescribers and practice managers who work in primary care. Data were
collected between February and March 2020.
2.1. Data Collection
The research team consisted of an independent researcher from Manchester Metropoli-
tan University (S.S.) and the project team (F.J., V.P., G.T., T.P.v.S. and E.T.) of the project
Building Rapid Interventions to reduce antibiotic resisTance (BRIT) and Public Health
England Behavioural Insights (PHEBI), who commissioned the research (N.G. and T.C.).
The BRIT project collects and analyses electronic healthcare data from participating pri-
mary care practices, interprets the results and then presents these insights to the health
professionals [https://www.britanalytics.uk/] (accessed on 15 February 2020).
A participatory approach, whereby a group of people are brought together to seek
their opinions, extract their knowledge and to solve problems in a collaborative and creative
environment, was used to inform the design of the workshop [12]. The workshop covered
the following areas: three feedback letters developed by PHEBI that were presented during
the workshop (see Figures 2–4), how GPs would want to receive information on their
own prescribing practice, presentation of prescribing data and mechanisms for facilitating
behaviour change. A topic guide was developed to explore and capture information on
these areas. Each workshop lasted three hours in an afternoon, with one workshop held in
Manchester and one in Nottingham. A third workshop was cancelled due to COVID-19
lockdown measures.
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2.2. Sampling and Recruitment
The specific aim of the study resulted in employing a purposive sampling strategy [13].
Participants were eligible for inclusion if they were a General Practitioner (GP) or other type
of prescriber (such as pharmacists) based in either Nottingham or Manchester. Participants
were recruited to the workshops by the BRIT team via email from existing BRIT dashboard
users. A follow-up email was sent two weeks later. Non-BRIT dashboard users were re-
cruited through the Clinical Research Network (CRN). In total, 85 GP practices were invited
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to take part in the study. As recruitment progressed, the inclusion criteria were widened
to include practice managers from both BRIT dashboard and non-BRIT dashboard using
practices to ensure a minimum of ten and a maximum of twenty participants were able to
attend each workshop. In total, fifteen participants were recruited for each workshop.
It was important that the workshops created an environment to enable all participants
an opportunity to share their experiences and opinions on each of the areas that would be
explored. In addition, it was important that the workshop provided a ‘safe space’ where
participants would feel at ease to be open and free with their opinions [14]. Participants
were encouraged to write down thoughts, comments and suggestions on post-it notes
allocated on each table. Discussions were facilitated by the independent researcher (S.S.)
with support from the BRIT team (F.J., V.P., G.T., T.P.v.S. and E.T.) in exploring prescribing
data presentation. Key discussion points were noted and agreed on flip chart paper with
each group of participants [13]. Furthermore, minutes of the workshops and observation
notes were taken in each workshop. Participants were asked to email any further comments
to the independent researcher on leaving the workshop. Earlier tests of the recording
equipment found that it was not possible to make a recording of suitable quality for
transcription therefore no audio recordings were made during the workshops due to the
size of the room and the number of participants.
2.3. Data Analysis
Data gathered by S.S., V.P., F.J. and G.T. were combined into one Word document,
with S.S. carrying out additional checks to ensure accuracy in data entry. The data were
then exported into NVivo to be thematically analysed. Thematic analysis is a widely used
method in analysing qualitative research data and documentation [15]. Data analysis took
place after the completion of the second workshop. Combining workshop minutes, work-
shop notes, observation notes and comments provided in a written format by participants
allowed S.S. to identify, organise and report themes using the steps outlined by Braun
and Clarke [16]. Key themes were described conceptually and were iteratively discussed
between S.S. and T.P.v.S. to ensure no disparities on emerging themes and differences.
NVivo 11 (QSR International Pty Ltd., 2014) (QSR International, Doncaster, Melbourne,
VIC, Australia) was used to aid in data management and analysis.
3. Results
The final response rate for the workshops was 67%. Overall, twenty participants took
part in the workshops: ten in Manchester and ten in Nottingham. Participants included a
clinical director (n = 1), GPs (n = 13), Practice Managers (n = 2), Prescribing Advisors (n = 3)
and a practice member of staff (n = 1). Participants came from different GP practices.
Four key themes emerged through the data analysis: (1) Our day-to-day reality, (2)
GPs are competitive, (3) Face-to-face support, and (4) Empowerment and engagement.
3.1. Theme 1: Our Day-to-Day Reality
Three examples of the feedback letters were provided for participants to view (see
Figures 2–4). In discussing these letters, opinions varied about the usefulness and effec-
tiveness of receiving letters about antibiotic prescribing from the CMO. Reflecting on their
own experience, most participants had either received or had seen a letter from the CMO.
Some participants said that their practice managers had received these letters, who had
then cascaded this to all prescribers within the practice, whereas others commented that
the GPs had received the letters directly.
All participants agreed that the headline sentence at the start of each letter, usually in
a red coloured font, had an impact on gaining the reader’s attention. However, responses
to receiving the feedback letters were mixed. On viewing the sample of letters during the
workshop, some participants recalled that they had ignored the letter they had received
after an initial read due because the data did not reflect the most up-to-date prescribing
data, whilst some used the letter as a tool for tackling antibiotic prescribing behaviours
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within their general practice. Some participants said that they would receive the letter and
think about doing something about it; however, day-to-day duties simply got in the way
and it was only a matter of days before the letter was forgotten about or binned.
Many participants felt that these letters were important to receive, however, they
commented that the data used to inform the letters were often out of date by the time
letters arrived at the general practice. In addition, participants who had received letters
themselves said that the data used were often from the winter period when prescriptions
would naturally increase due to flu and other seasonal factors.
In discussing the ‘next steps’ that were outlined down the right-hand side of the CMO
letters, most participants commented that these were not helpful or useful. They said that
these ‘next steps’ were already being actioned in many general practices but that they
simply did not work or were not in keeping with the reality of day-to-day workloads and
overstretched services.
3.2. Theme 2: GPs Are Competitive
All participants spoke of the importance of having a personalised approach for each
general practice and each GP. Participants discussed that it was not enough for the CMO
or the Clinical Commissioning Group (CCG) to send out an automated letter and expect
action to be taken, especially when general practices were under pressure to deliver on
other targets that were deemed to be more important.
In discussing the use of data in the CMO letters, participants were given three exam-
ples to look at. In discussing the letter which presented a graph, participants said that
the graphs themselves were not useful. However, if data were going to be used, then
these should be the latest available, and not coincide with seasonal increases. Furthermore,
letters should be sent out immediately once the latest prescribing data had been analysed.
However, several participants reflected on the potential challenges on relying on data when
prescribing data itself are subject to inconsistencies and in some cases, manipulation in the
way data are coded.
In providing further suggestions on presenting data within the letter, all participants
agreed that a localised ‘league table’ would be better than the current graph that is used.
The league table could potentially ‘benchmark’ general practices within a localised area,
with some participants discussing whether ranking each GP within a practice as a separate
table could be beneficial. Participants felt that this needed to be individualised per practice
to enable practises to see who is prescribing what, e.g., broad spectrum.
All participants agreed that GPs are competitive and therefore, a GP practice league
table would be more effective in changing prescribing behaviours. However, they said
that motivations for improving prescribing are focused on mainly being ‘average’ rather
than ‘top of the table’ due to the way the financial system works in relation to prescriptions.
Therefore, the system itself only motivates GPs to move towards the middle of a league
table rather than rise to the top. Some participants suggested that a league table with
indicators on where to improve next or with targeted areas for improvement at a practice
level would be better than the current three points on what to do next that are featured on
some letters.
Participants using the BRIT dashboard were able to provide further insight into how
the data in the letter could be better utilised. Rather than the ‘next steps’ on the right-hand
side, some BRIT dashboard users suggested that these could be replaced with a breakdown
of analysis tailored to the general practice receiving the letter. In addition, BRIT dashboard
users discussed the possibility to use analytics to provide one or two core recommendations
that would be manageable in its implementation. This could be worded as “This month,
we recommend that you look at improving . . . ”.
3.3. Theme 3: Face-to-Face Support
All participants felt that a much wider range of support was needed to change prescrib-
ing behaviours. This support was not just for the GPs and other prescribers themselves, but
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support for the practice managers, as well as how the local populations could be engaged
with to reduce antibiotic prescriptions requests. Interestingly, one group of participants
said that it was the older generation of GPs that they found the hardest to engage with in
changing antibiotic prescribing behaviours and not the younger generation of GPs.
Participants who were prescribers commented that they were sometimes having to
work with other GPs who did not want to change prescribing behaviours and said that
they needed support from outside of the organisations to enable them to do this effectively.
Where GPs had been able to engage well with changing prescribing behaviours, it they
said that these general practices had a wider range of resources and support to draw up.
This included information in a 2-page handout format, education materials on antibiotic
prescribing and podcasts.
In addition, there was a mixed response about how much support had been given by
CCGs for tackling the issues highlighted in the letter, with some CCGs not providing any
support and other CCGs contacting general practices several months after the letters had
been received. Some participants stated that they would prefer a face-to-face visit from the
CCG, whilst others would prefer to use social media or WhatsApp groups. All participants
agreed that a visit from the CCG would provide more influence on changing prescribing
behaviours through a focused discussion more than a letter.
3.4. Theme 4: Empowerment and Engagement
All participants agreed that Public Health England (PHE) needed to utilise a wider
range of engagement options if PHE was serious about reducing prescribing rates for
antibiotics. Participants commented that they were under a lot of pressure to meet other
targets, such as Quality Improvement and Quality Assurance targets, as well as working
with patients in a time- and resource-scarce setting.
Participants said that the way in which the CMO engages with GPs needed to change.
Some participants described the current process as feeling ‘out of touch’ with the realities
of frontline practice. Prescribers discussed the shift needed by the CMO from ‘telling off’ to
the ‘empowerment and education’ of GPs. Suggestions made by participants for engaging
with GPs included providing a condensed version of the letter that could be sent to all
GPs in a practice through WhatsApp. This should be tailored to each individual general
practice to enable the facilitation of discussions within the practice, particularly between a
practice manager and a GP. In addition, participants discussed the potential of utilising an
antibiotic champion within each practice as someone who could be the key contact for the
CCGs. Other participants suggested that a prescribing advisor could be utilised rather than
a pharmacist as another key contact person for future engagement with general practices.
Participants discussed the need for regular checks on progression, either through
Public Health England or the CCG in a face-to-face capacity. All participants agreed that a
more proactive and supportive approach from the CCGs and CMO was needed to really
make a difference in reducing prescribing rates. In addition, facilitated discussions with
prescribers and CCGs could be used in an ‘educational’ type meeting, where GPs could
discuss the issues with their populations, as well as difficulties in prescribing behaviours
in a safe environment without judgement.
4. Discussion
To our knowledge, this is the first qualitative study to report on how GPs in England
have received feedback letters from the CMO on prescribing practices and how they think
it could be improved. Four key themes emerged through our data analysis: (1) Our day-to-
day reality, (2) GPs are competitive, (3) Face-to-face support, and (4) Empowerment and
engagement. In addition, our study was been able to offer further understanding of the
types of support that GPs need to facilitate positive behaviour change and the types of
prescribing data that could be used in future behaviour interventions.
In discussing the ways in which the letters could be improved, participants agreed that
letters should be tailored to each practice and local context. Participants welcomed the use
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of general practice league table with tailored recommendations that could be implemented
easily as an alternative to prescribing data. Providing localised data comparisons would
bring the feedback letter to its original iteration when in the first year, this was a comparison
to other prescribers in local area teams. However, these were later disbanded and in
subsequent years GPs were given feedback compared to the national data.
There are now plenty of data showing that show peer-to-peer comparisons can de-
crease antibiotic prescribing. For example, the original social norms letter from the CMO
of England to GPs reduced prescribing by 3.3%, with the treatment group showing a
consistent reduction in prescribing every month for 6-months after receiving the letter, at
which point the letter was sent to the control group as well (Hallsworth et al., 2016). A
quasi-experimental evaluation of the CMO feedback letter with national comparisons in
2016–17 found a 3.69% decrease in prescribing, so it continued to be effective [10].
Elsewhere, an Australian study involving 6649 GPs tested the impact of letters by
the Australian Government’s CMO to high-prescribing GPs [17]. The RCT found that
letters containing peer comparison information outperformed the education-only letter
and resulted in a 14.8% reduction in antibiotic prescription rates [17]. This suggests
personalised approaches to social norm interventions benefit from peer to peer comparisons.
Interestingly, the most effective letter used a bar chart. This contradicts the results from our
workshops where GPs did not like the bar chart presented in one of the letters that they
were presented with. Further social norm interventions in the U.K should test feedback
letters with individual GP prescribing behaviour compared to other local GPs versus
national comparisons at scale to determine its effect on prescribing behaviour.
Study participants reflected that prescribing decision-making itself is complex and
can be determined by a range of factors such as geographical location and population
demographics. Future interventions that use social norm feedback should consider tailoring
letters to include localised contextual data and providing feedback on individual GP
antibiotic prescribing rather than at a practice level. In addition, whilst the original letters
were developed using a comprehensive review and analysis of the behaviours that support
antibiotic stewardship, and which of the drivers of these behaviours are amenable to
change [8], to improve their effectiveness, further research should consider an updated
large-scale process evaluation of the letter itself.
In considering the use of a social norms feedback letter to alter GP prescribing be-
haviour, our study suggests that feedback alone would not have its intended impact on
prescribing behaviours when GPs must meet other Quality Improvement and Quality
Assurance targets, as well as working with patients in a time and resource scarce setting.
Therefore, within primary care, any use of social norms should form part of a suite of
approaches aimed at reducing antibiotic prescribing, such as better diagnostic coding, more
precise prescribing guidelines and a deeper understanding of appropriate long-term uses
of antibiotics [4].
Our study participants agreed that proactive support from PHE and CCGs in the
form of general practice visits for discussions and sharing best practice would contribute
towards a shift in reducing antibiotic prescribing behaviours. This suggests that there is
either a lack of understanding around the roles and responsibilities of the CMO, PHE and
the CCGS, or there is a need for the CMO, PHE and CCGs to be more ‘visible’ at lower
levels in the health system, such as regionally or locally. Further research is needed to
explore this issue.
Similarly, utilising antimicrobial stewardship interventions (for example, an antibiotic
champion), as well as engaging with GPs through a range of media such as WhatsApp and
Twitter, can facilitate more prudent prescribing behaviours. Future social norm interven-
tions should consider testing the effectiveness of feedback of prescribing using different
communication methods.
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Limitations of Study
Our results are based on twenty participants attending one of two workshops in
England. The minimum number of participants attending the workshops was a result
of GPs dropping out on the day of each workshop due to a combination of seasonal flu
and start of the COVID-19 pandemic. This resulted in many GPs and other prescribers
not being able to attend the workshops. Therefore, there may be other issues that need
to be considered in relation to using feedback letters as a method of changing antibiotic
prescribing behaviours.
In addition, due to COVID-19 lockdown, only two workshops in two geographical
locations within England were completed. Therefore, our findings may not be generalisable
to the rest of England, or the U.K. In applying our findings to primary care, our study has
provided further suggestions in how to engage with GPs and other prescribers working
within primary care to reduce antibiotic prescribing, such as more proactive support from
local CCGs, tailored actions and recommendations for individual GP practices and GPs,
and the use of localised and up to date prescribing data in raising concerns in prescribing
behaviours.
5. Conclusions
In conclusion, the contents of future reminder letters from the CMO should be tailored
to each GP and reflect the local context. Consideration should be given to the types of data
presented in these letters, with an emphasis on comparing GPs to other local GPs in terms
of antibiotic prescribing. Similarly, further work is needed to clarify how, where and when
prescribing data are collected with those working in primary care.
Future interventions should consider using a wider range of engagement strategies,
rather than the reliance on a single feedback letter approach to reduce antibiotic prescribing
within primary care. This should include proactive support from CCGs in the form of
general practice visits for discussions, communicating with GPs using digital platforms
and social media, and the provision of fora for GPs to share best practice.
There is a need to be clear about the role, function and responsibilities of the CMO,
PHE and the CCGs, as well as the different roles and functions of organisations within the
NHS and how the wider health system operates, communicated with GPs and others that
work in primary care. Future research should explore GP perceptions of the role of the
CMO, PHE and CCGs and how these may affect antibiotic prescribing.
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